quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:35:00·1450d
PRRelease
Capstar Special Purpose Acquisition Corp. logo
Gelesis Holdings Inc. logo
PureTech Health plc logo

PureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022

CPSR· Capstar Special Purpose Acquisition Corp.GLS· Gelesis Holdings Inc.PRTC· PureTech Health plc
FinanceHealth Care
Original source

Companies

  • CPSR
    Capstar Special Purpose Acquisition Corp.
    Finance
  • GLS
    Gelesis Holdings Inc.
    Health Care
  • PRTC
    PureTech Health plc
    Health Care

Recent analyst ratings

  • Sep 9PRTCUpdateLeerink Partners$45.00
  • Jan 7PRTCUpdateSVB Leerink$70.00
  • Aug 25PRTCUpdateSVB Leerink$76.00

Related

  • PR11d
    PureTech Health: Notice of Results
  • PR21d
    PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine
  • PR21d
    PureTech Founded Entity Seaport Therapeutics Announces Positive Proof of Concept Topline Results from Ongoing Phase 1 Trial of GlyphAgo™ in Healthy Volunteers
  • PR29d
    PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo™ (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans
  • PR57d
    PureTech to Present at the Leerink Partners Global Healthcare Conference
  • PR63d
    PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
  • PR107d
    PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference
  • SEC126d
    SEC Form 6-K filed by PureTech Health plc
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022